These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain. Guo X, Wiley CA, Steinman RA, Sheng Y, Ji B, Wang J, Zhang L, Wang T, Zenatai M, Billiar TR, Wang Q. J Neuroinflammation; 2021 Jul 31; 18(1):169. PubMed ID: 34332594 [Abstract] [Full Text] [Related]
6. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses. Tang Q, Rigby RE, Young GR, Hvidt AK, Davis T, Tan TK, Bridgeman A, Townsend AR, Kassiotis G, Rehwinkel J. Immunity; 2021 Sep 14; 54(9):1961-1975.e5. PubMed ID: 34525337 [Abstract] [Full Text] [Related]
7. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation. de Reuver R, Dierick E, Wiernicki B, Staes K, Seys L, De Meester E, Muyldermans T, Botzki A, Lambrecht BN, Van Nieuwerburgh F, Vandenabeele P, Maelfait J. Cell Rep; 2021 Aug 10; 36(6):109500. PubMed ID: 34380029 [Abstract] [Full Text] [Related]
8. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways. Nakahama T, Kawahara Y. Int Immunol; 2023 Mar 14; 35(3):123-133. PubMed ID: 36469491 [Abstract] [Full Text] [Related]
9. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms. Sun T, Yu Y, Wu X, Acevedo A, Luo JD, Wang J, Schneider WM, Hurwitz B, Rosenberg BR, Chung H, Rice CM. Proc Natl Acad Sci U S A; 2021 Mar 23; 118(12):. PubMed ID: 33723056 [Abstract] [Full Text] [Related]
10. Adenosine Deaminase Acting on RNA 1 Associates with Orf Virus OV20.0 and Enhances Viral Replication. Liao GR, Tseng YY, Tseng CY, Lin FY, Yamada Y, Liu HP, Kuan CY, Hsu WL. J Virol; 2019 Apr 01; 93(7):. PubMed ID: 30651363 [Abstract] [Full Text] [Related]
11. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Rice GI, Kasher PR, Forte GM, Mannion NM, Greenwood SM, Szynkiewicz M, Dickerson JE, Bhaskar SS, Zampini M, Briggs TA, Jenkinson EM, Bacino CA, Battini R, Bertini E, Brogan PA, Brueton LA, Carpanelli M, De Laet C, de Lonlay P, del Toro M, Desguerre I, Fazzi E, Garcia-Cazorla A, Heiberg A, Kawaguchi M, Kumar R, Lin JP, Lourenco CM, Male AM, Marques W, Mignot C, Olivieri I, Orcesi S, Prabhakar P, Rasmussen M, Robinson RA, Rozenberg F, Schmidt JL, Steindl K, Tan TY, van der Merwe WG, Vanderver A, Vassallo G, Wakeling EL, Wassmer E, Whittaker E, Livingston JH, Lebon P, Suzuki T, McLaughlin PJ, Keegan LP, O'Connell MA, Lovell SC, Crow YJ. Nat Genet; 2012 Nov 01; 44(11):1243-8. PubMed ID: 23001123 [Abstract] [Full Text] [Related]
12. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation. de Reuver R, Verdonck S, Dierick E, Nemegeer J, Hessmann E, Ahmad S, Jans M, Blancke G, Van Nieuwerburgh F, Botzki A, Vereecke L, van Loo G, Declercq W, Hur S, Vandenabeele P, Maelfait J. Nature; 2022 Jul 01; 607(7920):784-789. PubMed ID: 35859175 [Abstract] [Full Text] [Related]
13. ADAR RNA Modifications, the Epitranscriptome and Innate Immunity. Quin J, Sedmík J, Vukić D, Khan A, Keegan LP, O'Connell MA. Trends Biochem Sci; 2021 Sep 01; 46(9):758-771. PubMed ID: 33736931 [Abstract] [Full Text] [Related]
14. RNA editing and immune control: from mechanism to therapy. Hu SB, Li JB. Curr Opin Genet Dev; 2024 Jun 01; 86():102195. PubMed ID: 38643591 [Abstract] [Full Text] [Related]
15. ADAR1, inosine and the immune sensing system: distinguishing self from non-self. Liddicoat BJ, Chalk AM, Walkley CR. Wiley Interdiscip Rev RNA; 2016 Jun 01; 7(2):157-72. PubMed ID: 26692549 [Abstract] [Full Text] [Related]
16. Effects of Aicardi-Goutières syndrome mutations predicted from ADAR-RNA structures. Fisher AJ, Beal PA. RNA Biol; 2017 Feb 01; 14(2):164-170. PubMed ID: 27937139 [Abstract] [Full Text] [Related]
17. What do editors do? Understanding the physiological functions of A-to-I RNA editing by adenosine deaminase acting on RNAs. Heraud-Farlow JE, Walkley CR. Open Biol; 2020 Jul 01; 10(7):200085. PubMed ID: 32603639 [Abstract] [Full Text] [Related]
18. ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep. Sinigaglia K, Wiatrek D, Khan A, Michalik D, Sambrani N, Sedmík J, Vukić D, O'Connell MA, Keegan LP. Biochim Biophys Acta Gene Regul Mech; 2019 Mar 01; 1862(3):356-369. PubMed ID: 30391332 [Abstract] [Full Text] [Related]
19. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions. Nakahama T, Kawahara Y. Int J Mol Sci; 2021 Oct 23; 22(21):. PubMed ID: 34768866 [Abstract] [Full Text] [Related]
20. Adenosine-to-inosine RNA editing in the immune system: friend or foe? Nakahama T, Kawahara Y. Cell Mol Life Sci; 2020 Aug 23; 77(15):2931-2948. PubMed ID: 31996954 [Abstract] [Full Text] [Related] Page: [Next] [New Search]